156 related articles for article (PubMed ID: 17043627)
1. Vascular tumor targeting.
Ahlskog J; Paganelli G; Neri D
Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):296-309. PubMed ID: 17043627
[TBL] [Abstract][Full Text] [Related]
2. Tumour vascular targeting.
Neri D; Bicknell R
Nat Rev Cancer; 2005 Jun; 5(6):436-46. PubMed ID: 15928674
[TBL] [Abstract][Full Text] [Related]
3. Targeting the tumor vasculature: a strategy to improve radiation therapy.
Siemann DW; Horsman MR
Expert Rev Anticancer Ther; 2004 Apr; 4(2):321-7. PubMed ID: 15056061
[TBL] [Abstract][Full Text] [Related]
4. Design of vascular endothelium-specific drug-targeting strategies for the treatment of cancer.
Molema G
Acta Biochim Pol; 2005; 52(2):301-10. PubMed ID: 15990916
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of radiation therapy by vascular targeting agents.
Siemann DW; Horsman MR
Curr Opin Investig Drugs; 2002 Nov; 3(11):1660-5. PubMed ID: 12476970
[TBL] [Abstract][Full Text] [Related]
6. Targeting the tumor blood vessel network to enhance the efficacy of radiation therapy.
Siemann DW; Shi W
Semin Radiat Oncol; 2003 Jan; 13(1):53-61. PubMed ID: 12520464
[TBL] [Abstract][Full Text] [Related]
7. Pathophysiologic effects of vascular-targeting agents and the implications for combination with conventional therapies.
Horsman MR; Siemann DW
Cancer Res; 2006 Dec; 66(24):11520-39. PubMed ID: 17178843
[TBL] [Abstract][Full Text] [Related]
8. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
9. Receptor radionuclide therapy of tumors: a road from basic research to clinical applications.
Bodei L; Paganelli G; Mariani G
J Nucl Med; 2006 Mar; 47(3):375-7. PubMed ID: 16513604
[No Abstract] [Full Text] [Related]
10. Role of tumor vascular architecture in drug delivery.
Narang AS; Varia S
Adv Drug Deliv Rev; 2011 Jul; 63(8):640-58. PubMed ID: 21514334
[TBL] [Abstract][Full Text] [Related]
11. Current status of therapy of solid tumors.
Jhanwar YS; Divgi C
J Nucl Med; 2005 Jan; 46 Suppl 1():141S-50S. PubMed ID: 15653662
[TBL] [Abstract][Full Text] [Related]
12. Tumour vascularisation: a druggable target.
Bishop-Bailey D
Curr Opin Pharmacol; 2009 Apr; 9(2):96-101. PubMed ID: 19056315
[TBL] [Abstract][Full Text] [Related]
13. Radiotargeted gene therapy.
Buchsbaum DJ; Chaudhuri TR; Zinn KR
J Nucl Med; 2005 Jan; 46 Suppl 1():179S-86S. PubMed ID: 15653667
[TBL] [Abstract][Full Text] [Related]
14. Targeting tumor stroma and exploiting mature tumor vasculature to improve anti-cancer drug delivery.
Bouzin C; Feron O
Drug Resist Updat; 2007 Jun; 10(3):109-20. PubMed ID: 17452119
[TBL] [Abstract][Full Text] [Related]
15. What "helps" tumors evade vascular targeting treatment?
Si ZC; Liu J
Chin Med J (Engl); 2008 May; 121(9):844-9. PubMed ID: 18701052
[TBL] [Abstract][Full Text] [Related]
16. Drug insight: vascular disrupting agents and angiogenesis--novel approaches for drug delivery.
Cooney MM; van Heeckeren W; Bhakta S; Ortiz J; Remick SC
Nat Clin Pract Oncol; 2006 Dec; 3(12):682-92. PubMed ID: 17139319
[TBL] [Abstract][Full Text] [Related]
17. Angiogenesis and vascular targeting: relevance for hyperthermia.
Horsman MR
Int J Hyperthermia; 2008 Feb; 24(1):57-65. PubMed ID: 18214769
[TBL] [Abstract][Full Text] [Related]
18. A pragmatic perspective on molecular targeted radionuclide therapy.
Larson SM; Krenning EP
J Nucl Med; 2005 Jan; 46 Suppl 1():1S-3S. PubMed ID: 15653645
[No Abstract] [Full Text] [Related]
19. Tumor necrosis factor-mediated interactions between inflammatory response and tumor vascular bed.
ten Hagen TL; Seynhaeve AL; Eggermont AM
Immunol Rev; 2008 Apr; 222():299-315. PubMed ID: 18364010
[TBL] [Abstract][Full Text] [Related]
20. Peptide-mediated targeting to tumor blood vessels of lung cancer for drug delivery.
Lee TY; Lin CT; Kuo SY; Chang DK; Wu HC
Cancer Res; 2007 Nov; 67(22):10958-65. PubMed ID: 18006841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
